A Phase 2 biomarker-enriched study of evofosfamide (TH-302) in patients with advanced melanoma. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • McWhirter, Elaine
  • Hamid, Omid
  • Chmielowski, Bartosz
  • Carvajal, Richard D
  • Jaffray, David A
  • Driscoll, Brandon
  • Shek, Tina
  • Yeung, Ivan
  • Keller, Harald
  • McKee, Trevor D
  • Pearce, Tillman E
  • Kroll, Stew
  • Joshua, Anthony M

publication date

  • May 20, 2015